Josh Cohen's Stock Ratings

Cantor Fitzgerald Analyst

Josh Cohen is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025

Overall Average Return

-62.3%

Smart Score

Overall Average Return Percentile

2nd

Number of Ratings

3

		Buy Now								Get Alert
05/18/2023	INVZ	Buy Now	Innoviz Technologies	$0.74	849.15%	Josh Cohen8%	→ $7	Reiterates	Overweight → Overweight	Get Alert
07/06/2021	HYLN	Buy Now	Hyliion Holdings	$1.63	942.94%	Josh Cohen8%	→ $17	Initiates	→ Overweight	Get Alert
05/19/2021	INVZ	Buy Now	Innoviz Technologies	$0.74	1798.31%	Josh Cohen8%	→ $14	Initiates	→ Overweight	Get Alert

Recent Analyst Stock Rating News

Trump Pulls the Plug on $5 Billion EV Charger Plan – Even Tesla's $31 Million is on Hold

CyberArk Q3 Earnings: Subscription Growth Soars, ARR Up, New CFO Announced And More

CyberArk Software Ltd reported Q3 2024 revenue growth of 26%, beating analyst consensus. EPS also beat estimates. CFO to step down in 2025. Company expects strong Q4 and 2024 revenue and EPS.

A Prosecutor Made A Key Allegation In Donald Trump's Hush-Money Case — Except It Doesn't Seem To Add Up

A prosecutor's allegation that former President Donald Trump had an affair with Karen McDougal during a sensitive period in his marriage is being disputed.

Jason Sudeikis, Josh Gad Return For 'The Angry Birds Movie 3' As Production Kicks Off

Production starts for 'Angry Birds Movie 3' with Jason Sudeikis and Josh Gad. Rovio, SEGA, and Prime Focus Studios bring the adventure to life.

YouTube Pranksters Dupe Tucker Carlson With Fake Interview Claiming Insider Knowledge Of Kate Middleton Photo Controversy

The prank was orchestrated by Josh Pieters and Archie Manners, who convinced Carlson that they had secured an interview with the disgruntled employee who had been fired for the photo's poor editing.

Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.

Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge

Billionaire hedge fund and NY Mets owner, Steve Cohen amped up his support for psychedelics R&D through a new investment of nearly 19 million in beneficially owned shares of Cybin Inc. (NYSE: CYBN).

How Russia Is Trying To Replace McDonald's And Peppa Pig

Companies have pulled out of Russia in record numbers after the country invaded Ukraine. Russia is retaliating against some of the companies by looking the other way or ending patent protection on trademarks. Here’s the latest.

Russia Could Allow People To Steal Patents, Operate Closed Businesses Such As McDonald's

The Russia-Ukraine conflict has caused many U.S.

Thinking About Buying Stock In Apple, Hyliion Or Virgin Galactic?

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why a stock is moving.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

Benzinga Pro on Macbook